SIU 2019

REVIEW UroToday

Viewing 1-20 of 48 articles

SIU 2019: Artificial Intelligence and Big Data

SIU 2019: How to Reduce Scientific Error (Clinical and Research)

SIU 2019: Extent of Lymph Node Dissection in Bladder Cancer

SIU 2019: Oncofid-P-B for the Treatment of BCG Unresponsive Carcinoma In Situ (CIS) of the Bladder – Results of the European Multicenter Phase 1 Study at the End of 12 Consecutive Weeks Intensive Course

SIU 2019: Enhanced Recovery After Surgery (ERAS) Radical Cystectomy and Urinary Diversion

SIU 2019: Changing the Paradigm in Intravesical Therapy for NMIBC

SIU 2019: Use of Molecular Biomarkers in Localized Prostate Cancer Management

SIU 2019: Re-TURBT – Yes, No, or Maybe?

SIU 2019: Developments in Imaging Prior to Biopsy — Are Systematic Biopsies Still Required?

SIU 2019: Use of Molecular Biomarkers in Screening

SIU 2019: Prostate Cancer Screening 2019: Doing It Right

SIU 2019: PET vs. MRI Directed Prostate Biopsy

SIU 2019: PSMA in Prostate Cancer – Diagnostic to Theranostics

SIU 2019: PET Imaging in Renal Cell Carcinoma and Urothelial Cancers

SIU 2019: Debate - Adjuvant Therapy for Muscle Invasive Bladder Cancer

SIU 2019: Debate - Neoadjuvant Therapy for Muscle Invasive Bladder Cancer

SIU 2019: Debate - Chemotherapy is Better than Immunotherapy as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer

SIU 2019: High Intensity Focused Ultrasound

SIU 2019: Debate - Immunotherapy is Better than Chemotherapy as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer

SIU 2019: Debate - Urinary Markers Are Irrelevant for Management of Bladder Cancer

1
2
3